Company: NDRA
Filing Date: 2025-03-31
Form Type: 8-K
Source: 0001654954-25-003611
Chunk: 1

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 8-K
Item: Item 7.01
Chunk 1
---
Item 7.01 Regulation FD Disclosure

Additionally, on March 31, 2025, the Company issued a press release regarding the Company’s business strategy, which is being furnished as Exhibit 99.2 to this Current Report on Form 8-K.

The information in Items 2.02 and 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 attached hereto is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “ Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.